Examination of the relationship between biomarkers in nasal discharge during initial wheezing and the onset of asthma in early childhood
Not Applicable
Recruiting
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000044655
- Lead Sponsor
- Dokkyo Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
Not provided
Exclusion Criteria
Preterm infants (less than 37 weeks) Children who required respiratory management during the newborn period, children with chronic lung disease Children with a history of autoimmune diseases or metabolic diseases Children who received treatment by steroids (inhalation, nasal drops, systemic administration) before sample collection (within 24 hours) Other children who the researcher deems inappropriate for participating in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differences in nasal discharge biomarkers tested at the time of screening between children in the IgE-related asthma group, non-IgE-related asthma group, and non-asthma group.
- Secondary Outcome Measures
Name Time Method